期刊
CURRENT MEDICINAL CHEMISTRY
卷 21, 期 34, 页码 3918-3935出版社
BENTHAM SCIENCE PUBL LTD
DOI: 10.2174/0929867321666140826115123
关键词
A(2A)R antagonists; aqueous solubility; cancer immunotherapy; molecular modeling; parkinson's disease; PET imaging; X-ray crystallography
The Adenosine A2A receptor is a member of the G-protein coupled receptor superfamily. It plays a key role in numerous physiological processes through the central nervous system and in peripheral tissues. Functional interactions between the A2A and dopamine D2 receptor has spurred interest in the use of antagonists as anti-Parkinson drugs. Additionally, oncology drugs are now being designed based on the potential for A2A antagonists to function as immunotherapeutics. From early studies based on classical xanthine type A2A antagonists through second generation agents, this mini review will cover aspects of the discovery, development, chemical synthesis and medicinal evaluation of this important class of drugs.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据